Peptide Codes Forum

Over the past eight months I have been conducting a self-experimentation protocol involving two peptides administered during varying fasting states, and I believe the data and subjective observations I have collected merit discussion here. I will attempt to be as precise as possible, though I recognize this is n=1 and should be interpreted accordingly.

Background: I have been intermittent fasting for approximately three years using a 20:4 window. Approximately fourteen months ago I began incorporating BPC-157 (administered subcutaneously at 250mcg daily) and GHK-Cu (also subcutaneous, 2mg three times weekly) into my protocol. For the first six months I administered both peptides approximately thirty minutes before breaking my fast, largely operating on the assumption that the absence of food-stimulated insulin would create a more favorable hormonal environment for peptide receptor interaction. This assumption, I now believe, was partially incorrect, or at least more complicated than I had appreciated.

The mistake I made, which I suspect others here may be replicating, was conflating the theoretical benefits of fasted-state hormone profiles with the practical reality of peptide stability and endogenous GH pulsatility patterns. There is reasonable mechanistic literature suggesting that GH secretagogues administered during sleep or deep fasting windows show amplified response, and I was extrapolating that logic uncritically to peptides with entirely different mechanisms of action. BPC-157 does not operate through the same pathways as, say, ipamorelin, and treating them equivalently in terms of timing was methodologically sloppy on my part.

What I observed during the initial six-month period was what I would characterize as inconsistent absorption. The tissue at injection sites showed variable responses, and my subjective sense of the gastroprotective and systemic anti-inflammatory effects that BPC-157 is documented to produce in animal models (Sikiric et al., 2018, among others in Curr Pharm Des) felt erratic. I cannot quantify this precisely, and I acknowledge that limitation fully.

Approximately eight months ago I restructured the protocol. I began administering BPC-157 roughly ninety minutes into my eating window, not immediately upon breaking the fast but after a modest protein intake of approximately 40 grams. My reasoning was that the mild insulin elevation from that meal might actually facilitate tissue delivery without meaningfully interfering with the peptide's mechanism. GHK-Cu I kept in a semi-fasted window, administered approximately two hours before breaking my fast in the morning, as the pro-collagen and antioxidant mechanisms described in Pickart et al. do not appear to be insulin-sensitive in the same way.

The subsequent eight months produced what I would characterize as noticeably more consistent outcomes. The joint and connective tissue recovery observations I was tracking improved in subjective consistency. Sleep architecture, which I monitor via Oura ring data (acknowledging the limitations of consumer-grade wearables), showed modestly improved HRV metrics during this period compared to the prior six months, though confounders are substantial and I would not make strong causal claims.

I want to pose several questions to those with more biochemistry depth than I possess on certain specifics.

First, is there any mechanism-based reason to believe that mild postprandial insulin elevation would materially help or harm BPC-157 bioavailability via subcutaneous administration? The subcutaneous route bypasses first-pass metabolism and I am uncertain whether systemic insulin levels at modest concentrations would influence peptide degradation at the injection site or distribution thereafter.

Second, for those who have experimented with extended fasting windows of 24 hours or longer, did peptide timing relative to the fast appear to matter in ways you could identify? I am curious specifically about whether the autophagic state that emerges after roughly 18 to 24 hours of fasting interacts meaningfully with peptide administration, as there is some theoretical basis for thinking autophagy upregulation could alter receptor expression profiles in ways that modify peptide response.

I am not presenting this as a controlled experiment. The confounders are numerous and I have done my best to list them honestly. But I think the timing question is underexamined in this community and worth serious discussion rather than defaulting to the simplified conventional wisdom of always administering peptides in a fasted state as though that recommendation were universal across all peptide classes.

dr_peptide_curious wrote:The mistake I made, which I suspect others here may be replicating, was conflating the theoretical benefits of fasted-state hormone profiles with the practical reality of peptide stability and endogenous GH pulsatility patterns.

yo this is a really solid writeup man, appreciate the detail. and yeah you hit on something i see people getting wrong ALL the time in these communities lol. dudes will just see "peptides = fasted" and apply that logic to literally everything regardless of mechanism. its like saying all supplements work the same because theyre all "supplements" lol. doesnt make sense.

your point about BPC not working through secretagogue pathways is exactly right. ive been saying this for a while. BPC is doing its thing via the VEGF and nitric oxide pathways mostly, it doesnt give a damn about your GH pulse timing the way ipamorelin or even CJC does. totally different animal.

on your first question about postprandial insulin and subq bioavailability - honestly i dont think modest insulin elevation is gonna hurt you much at all with subq admin. the first pass issue is already off the table like you said. if anything i could see slightly increased local blood flow from eating helping distribute it. thats pure broscience speculation on my part tho lol, i dont have citations for that.

re the autophagy question with extended fasts - ive done some 36-48hr fasts while on BPC and GHK-Cu and honestly couldnt tell a meaningful difference vs my normal 18:6 window. but my n is even smaller than yours so take that for what its worth

keep posting your data bro this is the kind of thread the community actually needs

gainz_peptide_bro wrote:BPC is doing its thing via the VEGF and nitric oxide pathways mostly, it doesnt give a damn about your GH pulse timing the way ipamorelin or even CJC does.

This is partially right but you're oversimplifying. BPC-157 has documented interactions with the dopaminergic and serotonergic systems as well, and the VEGF upregulation you mention is downstream of several signaling cascades, not the whole story. Stating it categorically "doesnt give a damn" about any particular variable is the kind of confident imprecision that causes problems.

To the original poster: the protocol restructuring you described is reasonable and your reasoning is sound. I disagree with one implication though. You're framing the initial fasted administration as clearly inferior based on your subjective improvement, but eight months of confounders including seasonal variation, cumulative peptide exposure, and simple familiarity with injection technique should give you pause before concluding timing was the operative variable. The improvement is real to you, fine, but the attribution is still a guess.

On your insulin question: subcutaneous absorption kinetics are not meaningfully altered by modest postprandial insulin at physiological concentrations. You're probably not optimizing much there. The tissue delivery argument is speculative.

On autophagy and receptor expression: theoretically interesting, practically nobody has clean data on this. Don't let the theoretical elegance convince you the effect size is meaningful.

The writeup is better than most of what gets posted here. The conclusions are still softer than you seem to think they are.

GrumpyOldResearcher wrote:subcutaneous absorption kinetics are not meaningfully altered by modest postprandial insulin at physiological concentrations. You're probably not optimizing much there.

ok so GrumpyOld kind of confirmed what gainz was saying but also dunked on him at the same time lol, fair tbh

OP this is a genuinely sick writeup and i dont say that lightly. most "protocol reviews" on here are like "i pinned 500mcg felt good 10/10" so the fact you actually tracked this over 8 months is dope.

i got a couple followup questions tho cuz im curious about some specifics

first - when you switched up the BPC timing to 90 min into your eating window with the 40g protein, was that always solid food or were you doing shakes? asking cuz i wonder if the digestion rate and how fast that insulin response actually hit mattered at all. like whey is gonna spike you different than chicken breast ya know

second thing and this is the one im MOST curious about - you mentioned the GHK-Cu you kept in a semi-fasted state. have you ever experimented with splitting the GHK-Cu to like a morning fasted dose AND a post-eating dose on your 3x weekly days? or keeping it strictly to one window? i stack GHK-Cu currently and i honestly havent been super methodical about timing it, which after reading your post i feel kinda dumb about lol

also the autophagy question is interesting but GrumpyOld is probably right that theres no clean data. still theoretically cool to think about tho

IronGutPeptideBro wrote:second thing and this is the one im MOST curious about - you mentioned the GHK-Cu you kept in a semi-fasted state. have you ever experimented with splitting the GHK-Cu to like a morning fasted dose AND a post-eating dose on your 3x weekly days?

Before I engage with the substance here let me be upfront that I have been reading this thread carefully and have some questions of my own that nobody seems to be asking, which I think need to be on the table before we go deeper into protocol optimization discussion.

dr_peptide_curious, I am not accusing you of anything, but I want to ask some specifics that will help me evaluate how much weight to put on your observations. Fourteen months of BPC-157 and GHK-Cu sourcing is a long time and unless you have been using the same verified supplier that entire period, your "inconsistent absorption" observations in the first six months may have absolutely nothing to do with timing relative to your fasting window. It may have been batch quality, peptide purity, degradation from improper storage, or simply receiving something that was not what it was labeled as. I have seen this exact pattern before where someone restructures their protocol, notices improvement, and concludes their timing hypothesis was validated when the more parsimonious explanation is that they switched suppliers or got a better batch around the same time.

So my first question is direct: did your source change at any point during this fourteen month window, and how are you validating peptide quality beyond trusting a vendor? Because GrumpyOldResearcher correctly identified the confounder problem but I think stopped short of the most obvious confounder of all, which is compound authenticity and purity variability.

Second question also for OP: the Oura HRV data you mentioned. Was your sleep schedule, training load, or dietary composition otherwise stable between the two protocol phases? Because HRV is exquisitely sensitive to acute stressors in ways that have nothing to do with peptide timing and using it as a soft endpoint here is genuinely problematic without accounting for that.

On the actual biochemistry questions being raised, GrumpyOldResearcher is largely correct about the insulin-subq absorption issue. The mechanistic argument for modest postprandial insulin materially improving subq peptide distribution is weak. Local blood flow changes post-meal are real but the magnitude is not going to meaningfully alter a 250mcg subq dose of a peptide with the stability profile BPC-157 has in peripheral tissue. I would not design a protocol around that variable.

The GHK-Cu split dosing question IronGutPeptideBro raised is actually interesting from a theoretical standpoint. GHK-Cu's copper-dependent mechanisms and its interactions with collagen remodeling pathways do not have the same pulsatile logic as GH secretagogue protocols, so I am genuinely uncertain whether split dosing buys you anything. But my honest answer is I do not know and I would be suspicious of anyone who claims to know with confidence given how thin the human data is on GHK-Cu dosing optimization specifically.

What I would really want to know before drawing conclusions from any of this is the sourcing history. Everything else is secondary to that.

SupplierSkeptic99 wrote:GrumpyOldResearcher correctly identified the confounder problem but I think stopped short of the most obvious confounder of all, which is compound authenticity and purity variability.

I didn't stop short of anything. I was addressing the biochemistry questions that were actually asked. You want credit for pointing out something obvious that every person in this hobby should already have in the back of their mind as a baseline assumption. Congratulations on knowing that peptide quality varies. Revolutionary contribution.

And look, you're not wrong that it's the most parsimonious explanation for the first-phase inconsistency. Fine. But the way you framed it as some devastating blindspot in my reply is annoying and inaccurate. I was addressing mechanism. You're addressing sourcing. These are not competing analyses, they're just different questions.

What ACTUALLY bothers me about your post is this line:

SupplierSkeptic99 wrote:I would not design a protocol around that variable.

Nobody is designing a protocol around postprandial insulin effects on subq absorption. The original poster was offering a HYPOTHESIS for why the restructured protocol felt different. There is a difference between "I wonder if this contributed" and "I am basing my entire dosing strategy on this." Stop arguing against a position nobody actually took.

The GHK-Cu split dosing question you called interesting and then immediately admitted you have no idea about. So do the rest of us. At least IronGut had the honesty to frame it as curiosity rather than dressing up uncertainty in skeptic costume.

GrumpyOldResearcher wrote:Nobody is designing a protocol around postprandial insulin effects on subq absorption. The original poster was offering a HYPOTHESIS for why the restructured protocol felt different. There is a difference between "I wonder if this contributed" and "I am basing my entire dosing strategy on this."

okay THANK YOU for saying this because I was reading SupplierSkeptic's post like... yes, sourcing variability is real and important and a totally valid thing to flag, but the way it was framed felt like it was trying to collapse this entire really rich discussion down to "your vendor might be bad" as if that's the end of the conversation. like, we can hold two ideas at once? sourcing can be a confounder AND the timing hypothesis can still be worth exploring? these are not mutually exclusive!

Anyway I want to actually add something constructive here because dr_peptide_curious this writeup is genuinely one of the better self-experimentation posts I've seen on this forum in a long time and I've been lurking here for years. The level of epistemic humility you brought to it - explicitly calling out your own confounders, not overclaiming causation - is exactly the kind of intellectual honesty that Ben Greenfield and people like Rhonda Patrick have been pushing for when it comes to n=1 biohacking, which is basically: rigor matters even when you can't control everything.

On the timing question specifically - your instinct to differentiate BPC-157 from secretagogues in terms of fasting logic really resonates with me. I went through a very similar evolution in my own thinking. I was listening to an older episode of the Human Performance Outliers podcast where they got into this exact issue of people applying "fasted = optimal" as a blanket rule across every compound in their stack and it's just... not how any of this works mechanistically. BPC-157's tissue regeneration and gastroprotective effects are operating through pathways that have their own logic completely separate from the GH pulsatility stuff. The 90 minutes into your eating window with protein first approach makes a lot of intuitive sense to me, not just for the modest insulin environment but also because your gut is actually engaged at that point, and even with subq admin there's something to be said for the overall physiological state being one of active recovery and nutrient partitioning rather than deep catabolic fasting.

I've been running a BPC-157 and TB-500 stack alongside GHK-Cu for about six months now and I made a very similar decision about timing differentiation. I keep the TB-500 in a pretty clean fasted window in the morning just because the systemic anti-inflammatory profile feels cleaner to me there, completely subjective, I know. But the BPC I moved to post first meal, similar reasoning to yours. The connective tissue recovery subjectively feels more consistent since I made that switch, though like everyone else in this thread I am obviously swimming in confounders.

The GHK-Cu split dosing question that IronGut raised is something I have been genuinely curious about too. My current approach is to keep it in that fasted morning window like OP described but I've wondered whether splitting it would do anything for the collagen remodeling angle specifically since collagen synthesis has some circadian patterns that are honestly underappreciated in most biohacking discussions. I've heard some stuff loosely referencing this in the context of vitamin C timing for collagen too, where there may be windows of enhanced fibroblast activity. Whether that logic scales to GHK-Cu I genuinely don't know but it's something I've been thinking about adding to my tracking.

On the autophagy interaction question - I find this theoretically beautiful even if GrumpyOld is right that the practical effect size is probably not as dramatic as the theory suggests. I've done extended 36-hour fasts periodically as part of my overall longevity protocol and I do find subjectively that peptide responses feel different during those windows, though whether that's autophagy-mediated receptor dynamics or just everything feeling different when you're 30 hours fasted is genuinely impossible for me to disentangle. David Sinclair's work on the interplay between mTOR suppression and cellular repair pathways at least gives you a framework for why the question is worth asking even if we don't have clean data.

Really glad this thread exists. This is exactly the kind of nuanced discussion that makes this community worth being in.

biohack_bella_87 wrote:your instinct to differentiate BPC-157 from secretagogues in terms of fasting logic really resonates with me. I went through a very similar evolution in my own thinking.

okay so I want to be clear upfront that I actually agree with a lot of what you said here, bella, and I think your overall framing about holding two ideas simultaneously (sourcing confounder AND timing hypothesis both being valid) is genuinely correct. the thread has been pretty good and I'm not here to fight anybody lol.

BUT. and this is a meaningful but. I want to gently push back on a couple of things because I've been in this hobby long enough to have made these exact mistakes myself and I feel like some of what got said in your post is going to send people down slightly wrong paths if I don't say something.

biohack_bella_87 wrote:not just for the modest insulin environment but also because your gut is actually engaged at that point, and even with subq admin there's something to be said for the overall physiological state being one of active recovery and nutrient partitioning rather than deep catabolic fasting.

okay so this is where I have to respectfully pump the brakes a little. I know this feels intuitively right, and I genuinely understand the logic you're reaching for, but "gut is engaged" and "overall physiological state of active recovery" are doing a lot of heavy lifting in that sentence for a subcutaneous administration route that has already completely bypassed the gut. like the whole premise of subq is that you're sideStepping the digestive environment entirely. the systemic effects of being in "active recovery mode" post-meal are real but they are much more diffuse and modest than I think that framing implies, and GrumpyOldResearcher was right to be skeptical that the magnitude is meaningful for a 250mcg subq dose.

I'm not saying OP's timing change was wrong or didn't produce real improvements, I genuinely think the restructured protocol makes more sense for independent reasons. I just think the specific mechanism you're reaching for to explain WHY it works better is a little hand-wavy in a way that might lead people to over-engineer the fed-state conditions thinking it's doing more work than it actually is.

biohack_bella_87 wrote:I've heard some stuff loosely referencing this in the context of vitamin C timing for collagen too, where there may be windows of enhanced fibroblast activity. Whether that logic scales to GHK-Cu I genuinely don't know

this is the part of your post I have the most complicated feelings about, lol. the circadian collagen synthesis angle is genuinely interesting and I don't want to dismiss it entirely because there IS some literature on fibroblast circadian rhythms that's at least worth knowing exists. but the vitamin C collagen timing stuff gets passed around in biohacking circles in a way that has gotten WAY ahead of what the actual evidence supports. most of that circadian collagen synthesis research is in vitro or in rodent models with specific tissue types and the translation to "therefore time your GHK-Cu differently" requires several inferential leaps that I don't think are justified yet. I say this as someone who spent like three months convinced I had optimized my collagen peptide and vitamin C timing before I got honest with myself about the quality of the data I was basing that on lol. the effect size, if real, is probably quite small.

biohack_bella_87 wrote:David Sinclair's work on the interplay between mTOR suppression and cellular repair pathways at least gives you a framework for why the question is worth asking

look I am not going to get into a Sinclair debate here because that's a whole other thread and a half, but I will say that using his work as a framework for peptide timing specifically is a bit of a stretch. his mTOR/autophagy work is foundational for thinking about fasting generally but it wasn't designed to generate predictions about exogenous peptide receptor dynamics during autophagic states. the theoretical elegance is genuinely there (GrumpyOldResearcher used almost those exact words earlier and I think they were right to be cautious about being seduced by it) but I've learned to be really suspicious of my own reasoning when I notice that I find a theory beautiful. that's usually the moment to double down on skepticism not relax into it lol.

none of this means the autophagy-peptide interaction question isn't worth asking. it absolutely is and OP raised it thoughtfully. I just think the Sinclair citation is lending it more mechanistic credibility than is really earned for this specific application.

to OP directly - your protocol restructuring writeup is genuinely excellent and I've been running a somewhat similar BPC-157 and GHK-Cu stack for about nine months now with a comparable evolution in my timing approach, so a lot of this resonates experientially even where I'm being critical of the mechanistic explanations offered in the thread. the connective tissue consistency improvement you described post-restructuring matches something I observed as well, and like you I am aggressively uncertain about which variable actually drove it.

anyway bella I'm not trying to pile on, your post added real value to the thread and most of it I agreed with. just wanted to flag where I think the reasoning got slightly ahead of the evidence because that's kind of the whole point of having these discussions instead of just nodding at each other lol.

lmao ok i gotta say something completely off topic for a sec because this thread has officially become the most ACADEMIC peptide discussion ive ever witnessed on this forum and im here for it but also slightly overwhelmed

like i came in here asking a pretty simple followup question about GHK-Cu split dosing and now we got GrumpyOld beefing with SupplierSkeptic, bella bringing in Ben Greenfield AND David Sinclair in the same post, and quantified_karen doing a full peer review of bellas post like this is journal club lmao

quantified_karen_lol wrote:I've learned to be really suspicious of my own reasoning when I notice that I find a theory beautiful. that's usually the moment to double down on skepticism not relax into it lol.

ok this actually slaps as life advice and im gonna apply it to way more than peptide timing lol. like maybe i should have been more skeptical when i thought stacking 4 GH peptides simultaneously was gonna be PEAK OPTIMIZATION and not just me injecting things at 10pm wondering why im not sleeping

anyway the split dosing question is still unanswered and i am still curious so if anyone has actually TRIED it and not just theorized about it beautifully, hit me up lol

also OP you still havent said if it was whey or solid food for that 40g protein. this matters to me personally for reasons i cannot fully articulate

quantified_karen_lol wrote:I've learned to be really suspicious of my own reasoning when I notice that I find a theory beautiful. that's usually the moment to double down on skepticism not relax into it lol.

okay I actually want to push back on this a little because I think this framing, while genuinely wise as a general principle, is being used to do some work it maybe shouldn't be doing in this specific context.

Like yes, beautiful theories can seduce us into bad reasoning. Totally valid. I have absolutely been there myself - I spent way too long convinced that my entire peptide stack needed to be reorganized around some intricate circadian timing framework that I had built up in my head and honestly looking back a lot of it was vibes dressed up as optimization lol. So I GET it.

But there's a version of reflexive skepticism toward elegant theories that can tip into dismissing mechanistic reasoning that is actually doing real work. The point biohack_bella made about differentiating BPC-157's tissue mechanisms from secretagogue logic isn't beautiful-theory-seduction, it's just... correct? Like that distinction has real mechanistic grounding and dr_peptide_curious actually applied it in a way that produced more consistent outcomes for them. That's not nothing.

I guess what I'm defending here is that the original post was already being appropriately humble about causation. OP wasn't saying "I found the beautiful theory and now I know the truth." They were saying "I changed my approach based on mechanism reasoning, my outcomes improved, and I'm genuinely uncertain which variable was responsible." That's exactly the right posture and I don't think the thread should collectively pressure that down into "well sourcing confounders so who knows."

The sourcing point from SupplierSkeptic is valid and worth asking. The subq-gut-engagement pushback from karen is fair. But the timing hypothesis is still worth taking seriously on its own terms and I don't want OP to walk away from this thread feeling like their eight months of careful observation got dismissed because we couldn't rule out every possible confounder. We never can. That's just n=1 territory.

Anyway I love this thread even when I'm arguing in it IronGut I'm also still waiting on the whey vs solid food answer because somehow that became the subplot I'm most invested in